IMP
Process View
positive regulation of synapse structural plasticity
Any process that activates, maintains or increases the frequency, rate or extent of synaptic structural plasticity.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of synapse structural plasticity"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.997 | ||
| WIPF1 | WAS/WASL interacting protein family, member 1 | 0.251 | ||
| SOS1 | son of sevenless homolog 1 (Drosophila) | 0.156 | ||
| ARHGEF7 | Rho guanine nucleotide exchange factor (GEF) 7 | 0.122 | ||
| PARD6B | par-6 partitioning defective 6 homolog beta (C. elegans) | 0.118 | ||
| STK17B | serine/threonine kinase 17b | 0.084 | Human | |
| SNX9 | sorting nexin 9 | 0.081 | ||
| STK17A | serine/threonine kinase 17a | 0.056 | Human | |
| RAB8B | RAB8B, member RAS oncogene family | 0.043 | ||
| PRKCZ | protein kinase C, zeta | 0.042 | ||
| RHOU | ras homolog gene family, member U | 0.032 | ||
| ITSN1 | intersectin 1 (SH3 domain protein) | 0.031 | ||
| TCEA2 | transcription elongation factor A (SII), 2 | 0.028 | ||
| LRRK2 | leucine-rich repeat kinase 2 | 0.024 | ||
| CREM | cAMP responsive element modulator | 0.022 | ||
| CSGALNACT2 | chondroitin sulfate N-acetylgalactosaminyltransferase 2 | 0.022 | ||
| BTK | Bruton agammaglobulinemia tyrosine kinase | 0.020 | ||
| PAK3 | p21 protein (Cdc42/Rac)-activated kinase 3 | 0.019 | ||
| PAK1 | p21 protein (Cdc42/Rac)-activated kinase 1 | 0.019 | ||
| ARHGEF6 | Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 | 0.019 | ||
| NTRK3 | neurotrophic tyrosine kinase, receptor, type 3 | 0.018 | ||
| LLGL1 | lethal giant larvae homolog 1 (Drosophila) | 0.017 | ||
| PAK7 | p21 protein (Cdc42/Rac)-activated kinase 7 | 0.015 | ||
| TIPARP | TCDD-inducible poly(ADP-ribose) polymerase | 0.014 | ||
| BCL10 | B-cell CLL/lymphoma 10 | 0.014 | ||
| GNA13 | guanine nucleotide binding protein (G protein), alpha 13 | 0.014 | ||
| MAP4K1 | mitogen-activated protein kinase kinase kinase kinase 1 | 0.014 | ||
| BAK1 | BCL2-antagonist/killer 1 | 0.014 | ||
| RAB27A | RAB27A, member RAS oncogene family | 0.014 | ||
| IQGAP2 | IQ motif containing GTPase activating protein 2 | 0.013 | ||
| LLGL2 | lethal giant larvae homolog 2 (Drosophila) | 0.013 | ||
| CRIPAK | cysteine-rich PAK1 inhibitor | 0.013 | ||
| TNK2 | tyrosine kinase, non-receptor, 2 | 0.012 | ||
| CBLB | Cas-Br-M (murine) ecotropic retroviral transforming sequence b | 0.012 | ||
| CDK14 | cyclin-dependent kinase 14 | 0.012 | ||
| PTK2 | PTK2 protein tyrosine kinase 2 | 0.011 | ||
| EZR | ezrin | 0.011 | ||
| HPCA | hippocalcin | 0.010 | ||
| GRIN1 | glutamate receptor, ionotropic, N-methyl D-aspartate 1 | 0.010 | ||
| STAC2 | SH3 and cysteine rich domain 2 | 0.010 |